Cargando…

Sarcopenia as a Prognostic Marker in Elderly Head and Neck Squamous Cell Carcinoma Patients Undergoing (Chemo-)Radiation

SIMPLE SUMMARY: Sarcopenia, i.e., the loss of muscle mass is a risk factor for reduced survival and increased treatment-associated toxicities in many cancers, and it increases with age. In this analysis, we investigated sarcopenia and sarcopenia dynamics during treatment in elderly patients (>65...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haehl, Erik, Alvino, Luisa, Rühle, Alexander, Zou, Jiadai, Fabian, Alexander, Grosu, Anca-Ligia, Nicolay, Nils H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688610/ https://www.ncbi.nlm.nih.gov/pubmed/36428629 http://dx.doi.org/10.3390/cancers14225536

Ejemplares similares

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
por: Rühle, Alexander, et al.
Publicado: (2021)

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
por: Rühle, Alexander, et al.
Publicado: (2023)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
por: Haehl, Erik, et al.
Publicado: (2021)

Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
por: Rühle, Alexander, et al.
Publicado: (2023)

Authors’ response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”
por: Rühle, Alexander, et al.
Publicado: (2023)

Patterns-of-Care Analysis for Radiotherapy of Elderly Head-and-Neck Cancer Patients: A Trinational Survey in Germany, Austria and Switzerland
por: Haehl, Erik, et al.
Publicado: (2022)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2022)

Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
por: Haehl, Erik, et al.
Publicado: (2020)

Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
por: Rühle, Alexander, et al.
Publicado: (2021)

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
por: Rühle, Alexander, et al.
Publicado: (2020)

Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients
por: Sprave, Tanja, et al.
Publicado: (2022)

The Value of Laboratory Parameters for Anemia, Renal Function, Systemic Inflammation and Nutritional Status as Predictors for Outcome in Elderly Patients with Head-and-Neck Cancers
por: Rühle, Alexander, et al.
Publicado: (2020)

App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial
por: Sprave, Tanja, et al.
Publicado: (2020)

The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
por: Rühle, Alexander, et al.
Publicado: (2021)

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial
por: Sprave, Tanja, et al.
Publicado: (2023)

Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma
por: Rühle, Alexander, et al.
Publicado: (2022)

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2023)

Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation
por: Rühle, Alexander, et al.
Publicado: (2020)

(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Radiation-induced toxicities and outcomes after radiotherapy are independent of patient age in elderly salivary gland cancer patients: results from a matched-pair analysis of a rare disease
por: Rühle, Alexander, et al.
Publicado: (2020)

Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites
por: Rühle, Alexander, et al.
Publicado: (2021)

The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
por: Rühle, Alexander, et al.
Publicado: (2022)

Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial
por: Rühle, Alexander, et al.
Publicado: (2021)

The Role of Palliative Radiotherapy in the Treatment of Spinal Bone Metastases from Head and Neck Tumors—A Multicenter Analysis of a Rare Event
por: Bostel, Tilman, et al.
Publicado: (2020)

Radiotherapy for nonagenarians: the value of biological versus chronological age
por: Sprave, Tanja, et al.
Publicado: (2020)

Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly
por: Bostel, Tilman, et al.
Publicado: (2023)

Hypoxia in Head and Neck Tumors: Characteristics and Development during Therapy
por: Bittner, Martin-Immanuel, et al.
Publicado: (2013)

Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis
por: Bielak, Lars, et al.
Publicado: (2020)

Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
por: Stoian, Raluca, et al.
Publicado: (2021)

Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study
por: Fabian, Alexander, et al.
Publicado: (2022)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
por: Spohn, Simon K.B., et al.
Publicado: (2022)

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients
por: Rühle, Alexander, et al.
Publicado: (2022)

Human mesenchymal stem cells are resistant to UV-B irradiation
por: Lopez Perez, Ramon, et al.
Publicado: (2019)

Radiotherapeutic management of cervical lymph node metastases from an unknown primary site – experiences from a large cohort treated with modern radiation techniques
por: Sprave, Tanja, et al.
Publicado: (2020)

Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer
por: Lazzeroni, Marta, et al.
Publicado: (2021)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Fazel, Asita, et al.
Publicado: (2020)

Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten: Ergebnisse der NRG-HN002-Studie
por: Rühle, Alexander, et al.
Publicado: (2021)

Aggressive Deeskalation der Strahlentherapie bei HPV-assoziierten Oropharynxkarzinomen auf der Basis der Hypoxiedynamik
por: Rühle, Alexander, et al.
Publicado: (2021)

Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie
por: Rühle, Alexander, et al.
Publicado: (2022)

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie
por: Rühle, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aqf0r5cjfbuglrchplfg1d1gq3